Calcium electroporation for the treatment of cutaneous metastases.

Julie Gehl0 个研究点目标入组 15 人开始时间: 2013年3月27日最近更新: 2017年4月3日

试验速览

暂无简介。

•1. Age > 18 years
•2. Patients should understand participants information.
•3. Histologically confirmed cutaneous metastases of any histology.
•4. At least 1. cutaneous metastases, between 0,5 to 3 cm, available to electroporation.
•5. Patient should have been offered standard treatment.
•6. At least 2 weeks since chemotherapy or radiotherapy.
•7. performance status < 2 (ECOG)
•8. Life expectancy >3 months
•9. platelet count >50 mia/l, INR<1,2
•10. Men and women of reproductive age must use effective contraception during the study.
•11. Signed informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 15
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 15

•1. previously treatment with bleomycin > 200.000 Units/m2
•2. Allergy to bleomycin.
•3. Clinically significant coagulopathy.
•4. Pregnancy or lactation.
•5. Participation in other clinical trial involving experimental drugs or participation in a clinical trial within 4 weeks before study treatment.

发起方

Julie Gehl